Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Schedule of Equity Fees) (Details)

v3.23.1
Related Party Transactions (Schedule of Equity Fees) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dividends receivable $ (3,866) $ (12,327)
Aevitas [Member]    
PIK Dividend date July 28  
Partner companies dividend $ 23 22
Avenue Therapeutics, Inc [Member]    
PIK Dividend date January 1  
Partner companies dividend $ 268 0
Baergic [Member]    
PIK Dividend date December 17  
Partner companies dividend $ 0 10
Cellvation [Member]    
PIK Dividend date October 31  
Partner companies dividend $ 10 9
Checkpoint [Member]    
PIK Dividend date January 1  
Partner companies dividend $ 1,885 6,598
Cyprium [Member]    
PIK Dividend date January 1  
Partner companies dividend $ 422 1,304
Helocyte [Member]    
PIK Dividend date January 1  
Partner companies dividend $ 90 141
Mustang    
PIK Dividend date January 1  
Partner companies dividend $ 1,109 4,212
Oncogenuity [Member]    
PIK Dividend date May 8  
Partner companies dividend $ 8 5
Urica    
PIK Dividend date November 25  
Partner companies dividend $ 51 $ 26